Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count b

The FDA has classified as Class II a recall by Accord Healthcare, Inc. of Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), affecting 90-count bottles (NDC 16729-454-15) and 1000-count bottles (NDC 16729-454-17). The product, manufactured by Intas Pharmaceuticals Limited in India, was recalled due to being subpotent, according to the recall notice.

Most relevant for: Children and adults requiring thyroid hormone replacement therapy who may have received subpotent levothyroxine tablets from the affected batches.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.